BREAKING NEWS
Rohit Sharma should change his tactics, be more attacking batting at No. 6: Ravi Shastri
Joe Root returns to England’s ODI squad for India tour, Champions Trophy; Ahmed in T20Is
Take steps to establish NIMHANS and diabetology units in Kalaburagi and Mysuru: CM Siddaramaiah
PM Modi receives Kuwait’s highest honour
RBI: After another status quo year, all eyes on a growth-propping rate cut with new Guv at helm
Zakir Hussain’s family shares first Instagram post after his death: Always together in love
Diljit Dosanjh denies blocking AP Dhillon on social media
India beat Bangladesh by 41 runs to bag Women’s U19 T20 Asia Cup
Belagavi: Man drives tractor over brother over property dispute, arrested
Siblings wanting to postpone exams behind bomb threats to Delhi schools
Multistorey building collapses in Punjab’s Mohali, several feared trapped
Rajasthan accident: Experts blame incomplete construction, sudden cuts; seek road safety action plan
ISRO & ESA agree to cooperate on astronaut training, mission implementation
Rafi@100: Mohammed Rafi is my musical father, says Sonu Nigam
Ambedkar row: Amit Shah bitten by ‘rabid dog,’ says Karnataka minister
Laurus Labs inks pact with MPP to produce molnupiravir
PTI, Jan 21, 2022, 11:46 AM IST
Image Source: Wikimedia
New Delhi: Drug firm Laurus Labs on Friday said it has inked a pact with Geneva-based MPP (Medicine Patient Pool) for manufacturing the oral COVID-19 antiviral medication molnupiravir.
”We are happy to sign an agreement to manufacture the oral COVID-19 anti-viral medication, which is an urgent need of the hour, this is one of the most critical step towards fighting the pandemic and we are happy to contribute to the mission,” Laurus Labs Founder and CEO Satyanarayana Chava said in a regulatory filing.
Molnupiravir is an orally administered ribonucleoside analog that inhibits the replication of SARS CoV2, and clinical studies have shown this drug to be active against the most common COVID-19 variants.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
RBI: After another status quo year, all eyes on a growth-propping rate cut with new Guv at helm
Front-running case: Sebi bans 9 entities from market , impounds illegal gains of over Rs 21 crore
Global trends, FIIs’ move to dictate trends in markets in holiday-shortened week: Analysts
GST Council postpones decision to cut tax on insurance, rate panel defers report submission
GST Council meet to decide on lower taxes on insurance policies, ATF inclusion
MUST WATCH
Latest Additions
Kannada Sahitya Sammelana: Food distribution creates stir
Rohit gets hit in nets, practice pitches on slower side
India & Kuwait elevate ties to strategic level; ink defence pact after PM Modi meets top Kuwaiti leaders
In Kuwait, PM Modi meets yoga practitioner, other influencers from Gulf country
Notorious gangster wanted in UAPA case arrested at Nepal border
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.